Medical Center Femiclinic EOOD
- Address
- Blvd. Dr. G. M. Dimitrov Block 65 Entrance A Fl. 1, 1172 Sofia, Bulgaria
Female Urogenital Diseases and Pregnancy Complications
Clinical research at this site addresses conditions affecting women's reproductive health, with a focus on improving outcomes for patients experiencing pain and fertility challenges. The work highlights Female Urogenital Diseases and Pregnancy Complications.
- Endometriosis‑related chronic pelvic pain
- Novel oral agents for endometriosis management
- Safety assessments in reproductive‑age women
- Strategies to reduce pregnancy‑related complications
The Medical Center Femiclinic EOOD partners with gynecologists to test new therapies that could lessen pain and enhance quality of life for women.
Skin and Connective Tissue Diseases
Research in dermatology focuses on inflammatory skin conditions, seeking effective and safe treatment options for chronic disease. This area is defined as Skin and Connective Tissue Diseases.
- Moderate‑to‑severe plaque psoriasis
- Atopic dermatitis
- Nummular dermatitis
- Evaluation of emerging biologics and small‑molecule agents
Ongoing studies aim to determine long‑term safety and improve symptom control, offering patients hope for better disease management.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Almirall S.A.1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Medical Center Femiclinic EOOD
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2a, Randomized, Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Multiple Subcutaneous Doses of TRIV-509 in Adults with Moderate to Severe Atopic Dermatitis | Triveni Bio Inc. | Phase II | Not Recruiting | Jan 2026 | — |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Zasocitinib | 2 | Unknown | 2025-04-01 | 2025-09-16 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.